# Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease

> **NCT04462276** · PHASE2 · COMPLETED · sponsor: **Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest** · enrollment: 68 (actual)

## Conditions studied

- Small Cell Lung Cancer Extensive Stage
- Thoracic Radiotherapy

## Interventions

- **DRUG:** Atezolizumab
- **RADIATION:** thoracic radiotherapy (TRT)

## Key facts

- **NCT ID:** NCT04462276
- **Lead sponsor:** Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-28
- **Primary completion:** 2024-09-02
- **Final completion:** 2024-09-02
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2025-01-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04462276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04462276, "Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04462276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*